美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
65862-710-03	65862-710	HUMAN PRESCRIPTION DRUG	Atazanavir Sulfate	Atazanavir	CAPSULE	ORAL	20180625	N/A	ANDA	ANDA204806	Aurobindo Pharma Limited	ATAZANAVIR SULFATE	100 mg/1	3 BLISTER PACK in 1 CARTON (65862-710-03) / 10 CAPSULE in 1 BLISTER PACK (65862-710-10)
65862-710-05	65862-710	HUMAN PRESCRIPTION DRUG	Atazanavir Sulfate	Atazanavir	CAPSULE	ORAL	20180625	N/A	ANDA	ANDA204806	Aurobindo Pharma Limited	ATAZANAVIR SULFATE	100 mg/1	500 CAPSULE in 1 BOTTLE (65862-710-05)
65862-710-60	65862-710	HUMAN PRESCRIPTION DRUG	Atazanavir Sulfate	Atazanavir	CAPSULE	ORAL	20180625	N/A	ANDA	ANDA204806	Aurobindo Pharma Limited	ATAZANAVIR SULFATE	100 mg/1	60 CAPSULE in 1 BOTTLE (65862-710-60)
65862-713-03	65862-713	HUMAN PRESCRIPTION DRUG	Atazanavir Sulfate	Atazanavir	CAPSULE	ORAL	20180625	N/A	ANDA	ANDA204806	Aurobindo Pharma Limited	ATAZANAVIR SULFATE	300 mg/1	3 BLISTER PACK in 1 CARTON (65862-713-03) / 10 CAPSULE in 1 BLISTER PACK (65862-713-10)
65862-713-05	65862-713	HUMAN PRESCRIPTION DRUG	Atazanavir Sulfate	Atazanavir	CAPSULE	ORAL	20180625	N/A	ANDA	ANDA204806	Aurobindo Pharma Limited	ATAZANAVIR SULFATE	300 mg/1	500 CAPSULE in 1 BOTTLE (65862-713-05)
65862-713-30	65862-713	HUMAN PRESCRIPTION DRUG	Atazanavir Sulfate	Atazanavir	CAPSULE	ORAL	20180625	N/A	ANDA	ANDA204806	Aurobindo Pharma Limited	ATAZANAVIR SULFATE	300 mg/1	30 CAPSULE in 1 BOTTLE (65862-713-30)
65862-713-90	65862-713	HUMAN PRESCRIPTION DRUG	Atazanavir Sulfate	Atazanavir	CAPSULE	ORAL	20180625	N/A	ANDA	ANDA204806	Aurobindo Pharma Limited	ATAZANAVIR SULFATE	300 mg/1	90 CAPSULE in 1 BOTTLE (65862-713-90)
65862-712-03	65862-712	HUMAN PRESCRIPTION DRUG	Atazanavir Sulfate	Atazanavir	CAPSULE	ORAL	20180625	N/A	ANDA	ANDA204806	Aurobindo Pharma Limited	ATAZANAVIR SULFATE	200 mg/1	3 BLISTER PACK in 1 CARTON (65862-712-03) / 10 CAPSULE in 1 BLISTER PACK (65862-712-10)
65862-712-05	65862-712	HUMAN PRESCRIPTION DRUG	Atazanavir Sulfate	Atazanavir	CAPSULE	ORAL	20180625	N/A	ANDA	ANDA204806	Aurobindo Pharma Limited	ATAZANAVIR SULFATE	200 mg/1	500 CAPSULE in 1 BOTTLE (65862-712-05)
65862-712-18	65862-712	HUMAN PRESCRIPTION DRUG	Atazanavir Sulfate	Atazanavir	CAPSULE	ORAL	20180625	N/A	ANDA	ANDA204806	Aurobindo Pharma Limited	ATAZANAVIR SULFATE	200 mg/1	180 CAPSULE in 1 BOTTLE (65862-712-18)
65862-712-60	65862-712	HUMAN PRESCRIPTION DRUG	Atazanavir Sulfate	Atazanavir	CAPSULE	ORAL	20180625	N/A	ANDA	ANDA204806	Aurobindo Pharma Limited	ATAZANAVIR SULFATE	200 mg/1	60 CAPSULE in 1 BOTTLE (65862-712-60)
65862-711-03	65862-711	HUMAN PRESCRIPTION DRUG	Atazanavir Sulfate	Atazanavir	CAPSULE	ORAL	20180625	N/A	ANDA	ANDA204806	Aurobindo Pharma Limited	ATAZANAVIR SULFATE	150 mg/1	3 BLISTER PACK in 1 CARTON (65862-711-03) / 10 CAPSULE in 1 BLISTER PACK (65862-711-10)
65862-711-05	65862-711	HUMAN PRESCRIPTION DRUG	Atazanavir Sulfate	Atazanavir	CAPSULE	ORAL	20180625	N/A	ANDA	ANDA204806	Aurobindo Pharma Limited	ATAZANAVIR SULFATE	150 mg/1	500 CAPSULE in 1 BOTTLE (65862-711-05)
65862-711-18	65862-711	HUMAN PRESCRIPTION DRUG	Atazanavir Sulfate	Atazanavir	CAPSULE	ORAL	20180625	N/A	ANDA	ANDA204806	Aurobindo Pharma Limited	ATAZANAVIR SULFATE	150 mg/1	180 CAPSULE in 1 BOTTLE (65862-711-18)
65862-711-60	65862-711	HUMAN PRESCRIPTION DRUG	Atazanavir Sulfate	Atazanavir	CAPSULE	ORAL	20180625	N/A	ANDA	ANDA204806	Aurobindo Pharma Limited	ATAZANAVIR SULFATE	150 mg/1	60 CAPSULE in 1 BOTTLE (65862-711-60)